US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ADARx Pharmaceuticals

19.54

-0.4000-2.01%

Pre-market: 20.050.5100+2.61%07:58 EDT

Volume:962.23K

Turnover:19.03M

Market Cap:2.00B

PE:-2.52

High:20.77

Open:19.99

Low:18.99

Close:19.94

52wk High:23.21

52wk Low:18.50

Shares:102.20M

Float Shares:102.20M

Volume Ratio:0.51

T/O Rate:0.94%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-7.7403

EPS(LYR):-6.4321

ROE:-38.89%

ROA:-14.90%

PB:-7.95

PE(LYR):-3.04

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering

Adarx Director Erez Chimovits Acquires 61,516 Shares Worth $1,045,772

Sector Update: Healthcare

MT Newswires Live

ADARx Pharmaceuticals Shares Soar in NASDAQ Debut After Upsized IPO

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/ADRX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ADRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADRX\",,,,,undefined,":{"symbol":"ADRX","market":"US","secType":"STK","nameCN":"ADARx Pharmaceuticals","latestPrice":19.54,"timestamp":1790884800000,"preClose":19.94,"halted":0,"volume":962225,"hourTrading":{"tag":"盘前","latestPrice":20.05,"preClose":19.54,"latestTime":"07:58 EDT","volume":26,"amount":522.619994,"timestamp":1790942323598,"change":0.51,"changeRate":0.0261,"amplitude":0.003071},"delay":0,"changeRate":-0.02006018054162498,"floatShares":102200905,"shares":102200905,"eps":-7.740306,"marketStatus":"Pre-Mkt","change":-0.4,"latestTime":"10-02 07:59:30 EDT","open":19.99,"high":20.77,"low":18.99,"amount":19029591.857375003,"amplitude":0.089268,"askPrice":21.61,"askSize":100,"bidPrice":17.15,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-7.740306,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790947800000},"marketStatusCode":1,"adr":0,"listingDate":1790308800000,"exchange":"NASDAQ","adjPreClose":19.54,"preHourTrading":{"tag":"盘前","latestPrice":20.05,"preClose":19.54,"latestTime":"07:58 EDT","volume":26,"amount":522.619994,"timestamp":1790942323598,"change":0.51,"changeRate":0.0261,"amplitude":0.003071},"postHourTrading":{"tag":"盘后","latestPrice":19.57,"preClose":19.54,"latestTime":"19:30 EDT","volume":11788,"amount":230324.56,"timestamp":1790897404808,"change":0.03,"changeRate":0.001535,"amplitude":0.0087},"volumeRatio":0.5126909969697809},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADRX\",,,,,undefined,":{"symbol":"ADRX","floatShares":102200905,"roa":"-14.90%","roe":"-38.89%","lyrEps":-6.432121,"volumeRatio":0.5126909969697809,"shares":102200905,"dividePrice":0,"high":20.77,"amplitude":0.089268,"preClose":19.94,"low":18.99,"week52Low":18.5,"pbRate":"-7.95","psRate":"325.94","week52High":23.21,"institutionHeld":0,"latestPrice":19.54,"eps":-7.740306,"divideRate":0,"volume":962225,"delay":0,"ttmEps":-7.740306,"open":19.99,"prevYearClose":17,"prevWeekClose":19.35,"prevMonthClose":19.94,"prevQuarterClose":19.94,"fiveDayClose":17,"twentyDayClose":17,"sixtyDayClose":17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADRX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADRX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADRX","date":"2026-09-30","current":-2.524448,"percent":0,"low":-25.080748,"twenty":-24.815781,"median":-24.41833,"eighty":-23.848887,"high":-23.469259,"avg":-24.322779,"sd":0.661348,"marketCap":2203845341},"quantilePoints":[{"date":"2026-09-30","current":-25.080748,"twenty":-24.815781,"median":-24.41833,"eighty":-23.848887,"marketCap":2203845341}],"updateTime":1790912980508},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADRX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672764099","title":"ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2672764099","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672764099?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:15","pubTimestamp":1790885700,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Oct.  01, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx) (Nasdaq: ADRX), a late-stage clinical biotechnology company developing next-generation siRNA therapeutics, announced t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/01/3373408/0/en/adarx-pharmaceuticals-announces-the-closing-of-full-exercise-of-underwriters-option-to-purchase-additional-shares-granted-in-its-initial-public-offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","KBWB","LU1988902786.USD","LU0158827781.USD","IE00BKVL7J92.USD","LU0225283273.USD","IE00B775SV38.USD","LU0557290698.USD","LU1989772923.USD","LU2487616109.SGD","LU0390134368.USD","LU1791710400.SGD","LU0210528500.USD","IE00BZ1G4Q59.USD","LU0795875169.SGD","LU1244550577.SGD","LU1548497426.USD","LU0971096721.USD","LU0882574139.USD","IAI","LU1720051017.SGD","BK4585","LU0528227936.USD","LU2023251221.USD","LU2347655156.SGD","LU1363072403.SGD","LU0053666078.USD","BK4516","LU2089284900.SGD","LU0098860793.USD","LU1989772840.SGD","BK4588","LU2111349929.HKD","LU0006306889.USD","LU0314104364.USD","LU1244550221.USD","LU2133065610.SGD","LU0267386448.USD","LU2028103732.USD","LU0106831901.USD","LU1791710582.SGD","ADRX","LU0795875086.SGD","LU1244550494.USD","IPOS","LU0912757837.SGD","LU0234570918.USD","LU0158827948.USD","IE00B3S45H60.SGD","LU2357305700.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672975314","title":"Adarx Director Erez Chimovits Acquires 61,516 Shares Worth $1,045,772","url":"https://stock-news.laohu8.com/highlight/detail?id=2672975314","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672975314?lang=en_us&edition=fundamental","pubTime":"2026-10-01 16:57","pubTimestamp":1790845022,"startTime":"0","endTime":"0","summary":"Adarx director Erez Chimovits acquires 61,516 shares worth $1,045,772Adarx Pharmaceuticals director Erez Chimovits reported an increase in indirect beneficial ownership to 9,292,025 common shares.Fili","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDLb2T6FX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Adarx Director Erez Chimovits Acquires 61,516 Shares Worth $1,045,772","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670842145","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2670842145","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670842145?lang=en_us&edition=fundamental","pubTime":"2026-09-26 03:28","pubTimestamp":1790364536,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose late Friday afternoon with the NYSE Healthcare Index gaining 0.4% and the State Street Health Care Select Sector SPDR ETF  adding 0.3%.The iShares Biotechnology ETF  increased 0.3%.In corporate news, ADARx Pharmaceuticals  shares jumped 18% in their Nasdaq debut after an initial public offering that raised $446.3 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0061475181.USD","BK4581","STT","LU1894683264.USD","IE0034235188.USD","XBI","BK4137","BK4550","LU0029874061.USD","BK4135","IE00B3QW5Z07.USD","XLV","ADRX","LU1883839398.USD","IE00BGHQF748.EUR","LU1894683348.USD","LU0128526141.USD","LABU","BK4585","IBB","IE00B64PRP62.GBP","BK4588","FDN","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442662","title":"ADARx Pharmaceuticals Shares Soar in NASDAQ Debut After Upsized IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442662","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442662?lang=en_us&edition=fundamental","pubTime":"2026-09-26 00:21","pubTimestamp":1790353284,"startTime":"0","endTime":"0","summary":"UPDATE 2-ADARx Pharmaceuticals shares soar in Nasdaq debut after upsized IPOSept 25 (Reuters)-Shares of ADARx PharmaceuticalsADRX.Orose 30% above their initial public offering price on Friday after th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nL4N45H0ML:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETRA","FHLC","LU0158827948.USD","XLV","PPH","BK4585","LU1929549753.HKD","LU0912757837.SGD","IXJ","JDOC","AGNG","LU2023251221.USD","ADRX","LU0320765646.SGD","LU1989771016.USD","FTXH","IE00B19Z3581.USD","VHT","LU0965509283.SGD","LU1003077747.HKD","LU1839511570.USD","LU0942090050.USD","LU1037948897.HKD","LU1983299246.USD","IE00BGHQF631.EUR","IE00B4R5TH58.HKD","IYH","LU0868494617.USD","LU0545039389.USD","LU0058720904.USD","LU0511384066.AUD","LU1548497426.USD","RXL","IE00BSNM7G36.USD","IE00B42XCP33.USD","IE0009355771.USD","ABBV","LU2237443465.HKD","LU2237443382.USD","GLAM","LU0098860793.USD","MEDX","LU1061106388.HKD","IE00BDGV0183.EUR","LU2129689605.HKD","IE0000B7K699.USD","PJP","LU0823416689.USD","LU1670627923.USD","TRUH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ADRX\",params:#limit:6,delay:false,,,undefined,":[]}}